Login

Bal Pharma Ltd.

₹83.77

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Bal Pharma Ltd.

  • NSE : BALPHARMA
Add Alert
Add Watchlist

₹83.77

₹83.77

0.1 (0.12%) - 3 Oct 2025 09:30 AM
  • NSE : BALPHARMA

About Company

Bal Pharma Limited is a leading Indian Pharmaceutical Company specializing in Prescription Drugs, Branded Formulations, APIs, Generic & OTC products, Intravenous Infusions and Bulk Drugs. It has a rich experience of 25 years in the International and Domestic operations. The company has 5 state of the art manufacturing facilities located pan India. The plants are approved by major International Regulatory Authorities like WHO-GMP, ISO 9001-2008. It has DMF approvals for Ebastine and Gliclazide in Japan and European markets. DMF filed for Bepotastine in US FDA. The company is adequately backed with in-house R&D, Clinical Research, Regulatory and other back end capabilities.

Market Cap. ₹ 133 Cr.
52 Week - High/Low ₹ 158/89
P/E Ratio 16.06
P/B Ratio 1.35
Enterprise Value ₹ 163 Cr.
ROE % 8.17
RSI Value 40.94
EMA 50 90.03
EMA 200 99.62
Market Cap. ₹ 133 Cr.
52 Week - High/Low ₹ 158/89
P/E Ratio 18.63
P/B Ratio 1.72
Enterprise Value ₹ 164 Cr.
ROE % 9.69
RSI Value 40.94
EMA 50 90.03
EMA 200 99.62
Add Parameters

Growth

Chart Icon
View Full Chart

Valuation

Calculators

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.